UBS Group’s Coeptis Therapeutics COEP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $640 | Sell |
82
-8,553
| -99% | -$66.8K | ﹤0.01% | 8445 |
|
|
2025
Q1 | $80.9K | Buy |
8,635
+1,870
| +28% | +$17.5K | ﹤0.01% | 5932 |
|
|
2024
Q4 | $37.2K | Buy |
6,765
+4,816
| +247% | +$26.5K | ﹤0.01% | 6264 |
|
|
2024
Q3 | $7.02K | Buy |
+1,949
| New | +$7.02K | ﹤0.01% | 6732 |
|
|
2024
Q1 | – | Sell |
-545
| Closed | -$8.54K | – | 8174 |
|
|
2023
Q4 | $8.54K | Buy |
+545
| New | +$8.54K | ﹤0.01% | 6335 |
|
|
2023
Q3 | – | Sell |
-11
| Closed | -$353 | – | 8340 |
|
|
2023
Q2 | $353 | Buy |
+11
| New | +$353 | ﹤0.01% | 7196 |
|
|
2023
Q1 | – | Sell |
-341
| Closed | -$10.4K | – | 8531 |
|
|
2022
Q4 | $10.4K | Buy |
+341
| New | +$10.4K | ﹤0.01% | 7315 |
|
|
2021
Q4 | – | Sell |
-63
| Closed | -$13K | – | 9135 |
|
|
2021
Q3 | $13K | Buy |
63
+35
| +125% | +$7.22K | ﹤0.01% | 6517 |
|
|
2021
Q2 | $6K | Sell |
28
-230
| -89% | -$49.3K | ﹤0.01% | 7322 |
|
|
2021
Q1 | $50K | Buy |
+258
| New | +$50K | ﹤0.01% | 5540 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7374 |
|